Huateng Biology Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Series B1
- Investors
-
7
Huateng Biology General Information
Description
Developer of innovative drugs, gene and cell therapy designed to promote medical innovation and safeguarding life and health. The company offers gene editing, surgical modeling, chemical diet induction and other advanced technologies to build animal models of human diseases, thereby enabling to provide a powerful tool platform for biomedical research and development.
Contact Information
Website
www.htscience.comCorporate Office
- 11th-12th Floor, Building B, Liandong U Valley
- Number 29 Bishan Street, Huangpu District
- Guangzhou, Guangdong
- China
Corporate Office
- 11th-12th Floor, Building B, Liandong U Valley
- Number 29 Bishan Street, Huangpu District
- Guangzhou, Guangdong
- China
Huateng Biology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series B1) | 01-Jan-2026 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | 29-Dec-2025 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 19-Aug-2024 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A1) | 30-Aug-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 05-Sep-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 24-May-2021 | Completed | Generating Revenue | |||
| 1. Seed Round | 29-Mar-2019 | Completed | Startup |
Huateng Biology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Huateng Biology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Huateng Biology Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Guangzhou Jinkong Fund | Asset Manager | Minority | ||
| Tianhe Investment | Government | Minority | ||
| Shenzhen Xipeng Private Equity Investment Fund | Growth/Expansion | Minority | ||
| Wanlian Tianze Capital Investment | Venture Capital | Minority | ||
| Yanghe Investment | Venture Capital | Minority |
Huateng Biology FAQs
-
When was Huateng Biology founded?
Huateng Biology was founded in 2019.
-
Where is Huateng Biology headquartered?
Huateng Biology is headquartered in Guangzhou, China.
-
What is the size of Huateng Biology?
Huateng Biology has 12 total employees.
-
What industry is Huateng Biology in?
Huateng Biology’s primary industry is Drug Discovery.
-
Is Huateng Biology a private or public company?
Huateng Biology is a Private company.
-
What is Huateng Biology’s current revenue?
The current revenue for Huateng Biology is .
-
Who are Huateng Biology’s investors?
Guangzhou Jinkong Fund, Tianhe Investment, Shenzhen Xipeng Private Equity Investment Fund, Wanlian Tianze Capital Investment, and Yanghe Investment are 5 of 7 investors who have invested in Huateng Biology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
